266 related articles for article (PubMed ID: 26222679)
1. Differential Expression and Enzymatic Activity of DPPIV/CD26 Affects Migration Ability of Cervical Carcinoma Cells.
Beckenkamp A; Willig JB; Santana DB; Nascimento J; Paccez JD; Zerbini LF; Bruno AN; Pilger DA; Wink MR; Buffon A
PLoS One; 2015; 10(7):e0134305. PubMed ID: 26222679
[TBL] [Abstract][Full Text] [Related]
2. DPPIV promotes endometrial carcinoma cell proliferation, invasion and tumorigenesis.
Yang X; Zhang X; Wu R; Huang Q; Jiang Y; Qin J; Yao F; Jin G; Zhang Y
Oncotarget; 2017 Jan; 8(5):8679-8692. PubMed ID: 28060721
[TBL] [Abstract][Full Text] [Related]
3. CD26/DPPIV down-regulation in endometrial stromal cell migration in endometriosis.
Tan CW; Lee YH; Tan HH; Lau MS; Choolani M; Griffith L; Chan JK
Fertil Steril; 2014 Jul; 102(1):167-177.e9. PubMed ID: 24825423
[TBL] [Abstract][Full Text] [Related]
4. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.
Fasolato S; Trevellin E; Ruvoletto M; Granzotto M; Zanus G; Boscaro E; Babetto E; Terrin L; Battocchio MA; Ciscato F; Turato C; Quarta S; Cillo U; Pontisso P; Vettor R
Life Sci; 2018 May; 200():134-141. PubMed ID: 29524519
[TBL] [Abstract][Full Text] [Related]
5. Dipeptidyl peptidase 9 (DPP9) in human skin cells.
Gabrilovac J; Čupić B; Zapletal E; Kraus O; Jakić-Razumović J
Immunobiology; 2017 Feb; 222(2):327-342. PubMed ID: 27682012
[TBL] [Abstract][Full Text] [Related]
6. Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.
Alonso N; Julián MT; Carrascal J; Colobran R; Pujol-Autonell I; Rodriguez-Fernández S; Teniente A; Fernández MA; Miñarro A; Ruiz de Villa MC; Vives-Pi M; Puig-Domingo M
PLoS One; 2015; 10(11):e0142186. PubMed ID: 26555789
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
8. DPPIV/CD26: a tumor suppressor or a marker of malignancy?
Beckenkamp A; Davies S; Willig JB; Buffon A
Tumour Biol; 2016 Jun; 37(6):7059-73. PubMed ID: 26943912
[TBL] [Abstract][Full Text] [Related]
9. Stromal cell-derived factor-1alpha-induced cell proliferation and its possible regulation by CD26/dipeptidyl peptidase IV in endometrial adenocarcinoma.
Mizokami Y; Kajiyama H; Shibata K; Ino K; Kikkawa F; Mizutani S
Int J Cancer; 2004 Jul; 110(5):652-9. PubMed ID: 15146553
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 (CD26) inhibitor sitagliptin exerts anti-inflammatory effects on rat insulinoma (RINm) cells via suppressing NF-κB activation.
Hu X; Liu S; Liu X; Zhang J; Liang Y; Li Y
Endocrine; 2017 Mar; 55(3):754-763. PubMed ID: 27612849
[TBL] [Abstract][Full Text] [Related]
11. CD26/dipeptidyl peptidase IV expression in human lymphomas is restricted to CD30-positive anaplastic large cell and a subset of T-cell non-Hodgkin's lymphomas.
Carbone A; Cozzi M; Gloghini A; Pinto A
Hum Pathol; 1994 Dec; 25(12):1360-5. PubMed ID: 8001932
[TBL] [Abstract][Full Text] [Related]
12. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
[TBL] [Abstract][Full Text] [Related]
13. CD26/dipeptidyl peptidase IV differentially regulates the chemotaxis of T cells and monocytes toward RANTES: possible mechanism for the switch from innate to acquired immune response.
Iwata S; Yamaguchi N; Munakata Y; Ikushima H; Lee JF; Hosono O; Schlossman SF; Morimoto C
Int Immunol; 1999 Mar; 11(3):417-26. PubMed ID: 10221653
[TBL] [Abstract][Full Text] [Related]
14. Glycosaminoglycans Regulate CXCR3 Ligands at Distinct Levels: Protection against Processing by Dipeptidyl Peptidase IV/CD26 and Interference with Receptor Signaling.
Metzemaekers M; Mortier A; Janssens R; Boff D; Vanbrabant L; Lamoen N; Van Damme J; Teixeira MM; De Meester I; Amaral FA; Proost P
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703769
[TBL] [Abstract][Full Text] [Related]
15. Sitagliptin inhibit human lymphocytes proliferation and Th1/Th17 differentiation in vitro.
Pinheiro MM; Stoppa CL; Valduga CJ; Okuyama CE; Gorjão R; Pereira RM; Diniz SN
Eur J Pharm Sci; 2017 Mar; 100():17-24. PubMed ID: 28065853
[TBL] [Abstract][Full Text] [Related]
16. Role for dipeptidyl peptidase IV in tumor suppression of human non small cell lung carcinoma cells.
Wesley UV; Tiwari S; Houghton AN
Int J Cancer; 2004 May; 109(6):855-66. PubMed ID: 15027119
[TBL] [Abstract][Full Text] [Related]
17. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
[TBL] [Abstract][Full Text] [Related]
18. CD26/DPPIV inhibition alters the expression of immune response-related genes in the thymi of NOD mice.
Julián MT; Alonso N; Colobran R; Sánchez A; Miñarro A; Pujol-Autonell I; Carrascal J; Rodríguez-Fernández S; Ampudia RM; Vives-Pi M; Puig-Domingo M
Mol Cell Endocrinol; 2016 May; 426():101-12. PubMed ID: 26911933
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and characterization of human dipeptidyl peptidase IV/CD26 in Sf9 insect cells.
Dobers J; Zimmermann-Kordmann M; Leddermann M; Schewe T; Reutter W; Fan H
Protein Expr Purif; 2002 Aug; 25(3):527-32. PubMed ID: 12182835
[TBL] [Abstract][Full Text] [Related]
20. CD26/dipeptidyl peptidase IV and its role in cancer.
Pro B; Dang NH
Histol Histopathol; 2004 Oct; 19(4):1345-51. PubMed ID: 15375776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
